Options Brief: Gilead Sciences

Shares of Gilead Sciences GILD are lower on the session by 0.85%, trading at $40.65. Overall call volume is now running at 4.43x the daily average, with 9% of all calls traded being purchases on the offer. 19,059 contracts have traded on the session so far. Gilead Sciences, Inc. is a biopharmaceutical company. The company focuses on the development and commercialization of human therapeutics for life threatening diseases.